PolyPeptide Group AG

Swiss Stock Exchange:PPGN.SW

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Chemicals & Advanced Materials

💄 Cosmetics

💊 Pharmaceuticals

🔍 Research & Consulting

Location

Switzerland

Market Cap

USD 898.02 M

Share Price

USD 27.22

Avg Daily Volume

29,889

Change (1 day)

1.19%

Change (1 year)

-22.52%

Change (YTD)

-13.34%

PolyPeptide Group AG EBIT Margin for the year ending December 31, 2024: -1.27%

PolyPeptide Group AG EBIT Margin is -1.27% for the year ending December 31, 2024, a -92.28% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

PolyPeptide Group AG EBIT Margin for the year ending December 31, 2023 was -16.42%, a -577.84% change year over year.
PolyPeptide Group AG EBIT Margin for the year ending December 31, 2022 was 3.44%, a -84.53% change year over year.
PolyPeptide Group AG EBIT Margin for the year ending December 31, 2021 was 22.21%, a 21.52% change year over year.
PolyPeptide Group AG EBIT Margin for the year ending December 31, 2020 was 18.28%, a 10.64% change year over year.